Please use this identifier to cite or link to this item:
Title: Role of Imunomet in upper respiratory tract disorders: A randomized double blind placebo controlled clinical trial
Authors: Adhikari, Anjan
Biswas, Sharmistha
Raman De, Radha
Mitra, Achintya
Hazra, Jayram
Debnath, P K
Keywords: Imunomet;Upper respiratory tract infections;Placebo;Clinical trial
Issue Date: Apr-2013
Publisher: NISCAIR-CSIR, India
IPC Code: Int. Cl.8:A61K 39/00, A01D 11/00, A01D 4/00, A01D 4/03, A01D 4/13, A01D 4/64
Abstract: Upper respiratory tract disorders comprise 87.5% of total acute respiratory morbidity in children in India. This has become a major community health problem. The symptoms are often self limiting and many a time caused by viruses, however, recurrent attacks may lead to distinct morbidity. This study was conducted in hospital outpatient department on children who have been attending at frequent interval with complaints of sore throat, pharyngitis, tonsillitis. They were administered Imunomet syrup or tablet for a period of 8 weeks. At the end of the treatment, about 84% patients responded well to treatment and 16% patients had fair response to treatment. None of the patients showed any adverse reaction to treatment. The syrup was found to be palatable.
Page(s): 281-283
ISSN: 0975-1068 (Online); 0972-5938 (Print)
Appears in Collections:IJTK Vol.12(2) [April 2013]

Files in This Item:
File Description SizeFormat 
IJTK 12(2) 281-283.pdf27.23 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.